From: Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma
 | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Factors Selected | ||||
 AST, IU/L | 1.00 (1.00-1.00) | <0.001 | 1.01 (1.00-1.01) | 0.010 |
 GGT, IU/L | 1.00 (1.00-1.00) | <0.001 | 1.01 (1.00-1.01) | 0.001 |
 WBC, 109/L | 1.16 (1.10-1.22) | <0.001 | 1.09 (1.02-1.16) | 0.007 |
 NLR | 1.33 (1.28-1.38) | <0.001 | 1.15 (1.10-1.21) | <0.001 |
 PTA, % | 0.98 (0.97-0.98) | <0.001 | 0.98 (0.97-0.99) | <0.001 |
 AFP ≥ 400 ng/mL | 2.82 (2.28-3.49) | <0.001 | 1.36 (1.06-1.76) | 0.017 |
 Tumor number ≥ 3 | 2.19 (1.79-2.69) | <0.001 | 1.27 (1.01-1.61) | 0.044 |
 Tumor size ≥ 5 cm | 3.12 (2.52-3.86) | <0.001 | 1.56 (1.22-1.99) | <0.001 |
 Lymph node metastasis | 4.22 (3.12-5.72) | <0.001 | 1.66 (1.18-2.34) | 0.004 |
 Portal vein involvement | 9.45 (7.48-11.95) | <0.001 | 4.85 (3.62-6.49) | <0.001 |
Factors not Selected | ||||
 Age, yr | 0.99 (0.98-1.00) | 0.075 |  |  |
 Male | 0.75 (0.57-1.00) | 0.047 |  |  |
 Familyhistory of HCC | 1.16 (0.87-1.55) | 0.310 |  |  |
 History of smoking | 1.17 (0.96-1.44) | 0.127 |  |  |
 History of alcohol use | 1.46 (1.19-1.79) | <0.001 |  |  |
 ALT, IU/L | 1.00 (1.00-1.00) | 0.033 |  |  |
 TBIL, μmol/L | 1.01 (1.01-1.01) | <0.001 |  |  |
 ALB, g/L | 0.96 (0.95-0.98) | <0.001 |  |  |
 ALP, IU/L | 1.00 (1.00-1.01) | <0.001 |  |  |
 NC, 109/L | 1.36 (1.28-1.45) | <0.001 |  |  |
 LC, 109/L | 0.55 (0.46-0.67) | <0.001 |  |  |
 PLT, 109/L | 1.00 (1.00-1.00) | 0.060 |  |  |
 Cr, μmoI/L | 1.00 (1.00-1.01) | <0.001 |  |  |
 INR | 1.01 (0.96-1.05) | 0.795 |  |  |